Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Breast Neoplasms"
topic_facet:"Phase: Phase 3"
topic_facet:"Recruitment Status: Recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Breast+Neoplasms%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
PubPharm (209)
1
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer : TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Hypofractionated LocoRegional Radiotherapy in Breast Cancer : Randomized Trial of Hypofractionated LocoRegional Radiotherapy in Breast Cancer and Lymphedema (RHEAL)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) : A Phase III Randomized, Open-Label Study Evaluating Efficacy and Safety of Giredestrant Compared With Fulvestrant, Both Combined With a CDK4/6 Inhibitor, in Patients With Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer With Resistance to Prior Adjuvant Endocrine Therapy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer : A Phase III, Open-label, Randomised Study of Neoadjuvant Datopotamab Deruxtecan (Dato-DXd) Plus Durvalumab Followed by Adjuvant Durvalumab With or Without Chemotherapy Versus Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab With or Without Chemotherapy for the Treatment of Adult Patients With Previously Untreated Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer (D926QC00001; TROPION-Breast04)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA) : A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292) : A Phase Ib/III, Open-label, Randomised Study of Capivasertib Plus CDK4/6 Inhibitors and Fulvestrant Versus CDK4/6 Inhibitors and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced, Unresectable or Metastatic Breast Cancer (CAPItello-292)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer : Phase III Trial of Neoadjuvant Durvalumab (NSC 778709) Plus Chemotherapy Versus Chemotherapy Alone for MammaPrint Ultrahigh (MP2) Hormone Receptor (HR) Positive / Human Epidermal Growth Factor Receptor (HER2) Negative Stage II-III Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. : Randomized, Open-Label Study of the Bria-IMT Regimen and Check Point Inhibitor vs Physicians' Choice in Advanced Metastatic Breast Cancer.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast Cancer : A Multicentre, Randomized, Open-label, Controlled Phase Ш Clinical Study to Evaluate the Efficacy and Safety of DP303c Versus Trastuzumab Emtansine in Patients With HER2-positive Advanced Breast Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer : A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer, Whose Tumors Express PD-L1
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Breast Neoplasms
Filter aufheben
Thema: Phase: Phase 3
Filter aufheben
Thema: Recruitment Status: Recruiting
Medienart
209
Aufsätze
209
E-Artikel
209
E-Ressourcen
Zeitschriftentitel
209
ClinicalTrials.gov
Thema
209
610
Breast Neoplasms
Phase: Phase 3
Recruitment Status: Recruiting
209
Study Type: Interventional
32
Triple Negative Breast Neoplasms
20
Medical Condition: Breast Cancer
8
Recurrence
6
Neoplasms
5
Neoplasm Metastasis
4
Carcinoma
4
Chronic Pain
3
Brain Neoplasms
3
Lymphedema
3
Medical Condition: Triple Negative Breast Cancer
2
Arthralgia
2
Breast Diseases
2
Carcinoma, Ductal, Breast
2
Carcinoma, Renal Cell
2
Cardiotoxicity
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
196
2020-
13
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
209
Englisch
Haven't found what you're looking for?
Wird geladen...